Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Soren Echwald, Palle Schelde

Premium

Søren Echwald has been named CEO at Anapa Biotech. The Danish biotech, previously called QuantiBact, is developing molecular tools to enhance the performance of natural nucleic acids in PCR and hybridization-based assays.

Echwald joins Anapa from Exiqon, where he was vice president of business development. He takes over the CEO position from Palle Schelde, who has left the company to pursue other opportunities in the biotech industry, Anapa said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.